Novartis AG is 7.2x more valuable than TEVA PHARMACEUTICAL INDUSTRIES LTD by market capitalization ($283.13 B vs $39.12 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | TEVA | NVS |
|---|---|---|
| Market cap | $39.12 B | $283.13 B |
| US-listed rank | #392 | #47 |
| Revenue (latest FY) | $17.26B | - |
| Net income (latest FY) | $1.41B | - |
| Net margin | 8.2% | - |
| P/E (trailing FY) | 27.7 | - |
| SEC filings | 2,473 | 947 |
Novartis AG is 7.2x more valuable than TEVA PHARMACEUTICAL INDUSTRIES LTD by market capitalization ($283.13 B vs $39.12 B).
Full pages: TEVA PHARMACEUTICAL INDUSTRIES LTD and Novartis AG, or browse the full rankings.